DC Firm Helped Ranbaxy Avoid FDA Scrutiny, RICO Suit Says
The since-closed Washington boutique food and drug firm Buc & Beardsley LLP helped shield Indian pharmaceutical company Ranbaxy from regulatory scrutiny, according to a lawsuit filed Wednesday in Boston federal court...To view the full article, register now.
Already a subscriber? Click here to view full article